Longshenrongfa Pharmaceutical Industry: In the first half of the year, the net profit attributable to the parent company was 27.9561 million yuan, a year-on-year increase of 27.48%

Longshenrongfa Pharmaceutical Industry disclosed its semi-annual report on August 22, showing that the company achieved operating revenue of 496 million yuan in the first half of the year, a year-on-year decrease of 8.21%; the net profit attributable to shareholders of the listed company was 27.9561 million yuan, a year-on-year increase of 27.48%; basic earnings per share were 0.0922 yuan